ISPOR Announces New Chief Financial Officer

Published Feb 4, 2025

Kate Tarpey Appointed to Serve in New Position for the Organization

Lawrenceville, NJ, USA—February 4, 2025—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that Kate Tarpey has been appointed as chief financial officer for the Society. This is a new position at ISPOR and speaks to the growth of both the Society and the increasing role of health economics and outcomes research (HEOR) in healthcare.

Ms Tarpey comes to ISPOR with more than 20 years of experience in nonprofit financial operations management. Most recently, she served as chief financial officer for Planned Parenthood of Wisconsin, Inc. Previously, she has worked for education and nonprofit organizations in finance and operational roles. She also serves as an adjunct instructor at Marquette University in Milwaukee, Wi, USA.

“We are very excited to have Kate join ISPOR in this critically important role,” stated ISPOR’s CEO and Executive Director, Rob Abbott. “Kate brings significant experience to our organization, both in finance and in the nonprofit realm. Her leadership will be essential as our organization continues to grow in both size and impact.”

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×